TELA is expected to report earnings to fall 36.69% to -26 cents per share on March 19
Q4'24
Est.
$-0.27
Q3'24
Missed
by $0.02
Q2'24
Missed
by $0.05
Q1'24
Beat
by $0.26
Q4'23
Missed
by $0.11
The last earnings report on November 07 showed earnings per share of -41 cents, missing the estimate of -40 cents. With 171.50K shares outstanding, the current market capitalization sits at 139.76M.
a commercial stage medical technology company, which focuses on designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.